Fight CRC Patient Resource Group – Launch

FINDING RESOURCES Colorectal cancer resources shouldn’t be hard to find. Fight Colorectal Cancer knows that many patients, caregivers and survivors find themselves asking the same questions:  Where can I find reliable and trusted information about my diagnosis and treatment plan?  How do I stay up-to-date on the latest colorectal cancer news?  Is there one place where…  Read More

Another treatment option coming down the pike: TAS-102

Fight Colorectal Cancer stays actively involved in the research process from beginning to end. Part of our role in research is monitoring the progress of new drugs – drugs that may be used in treatment plans of colorectal cancer in the future. We actively work with drug companies to stay up-to-date on the latest treatments so…  Read More

Cancer Prevention: Skinnier, Wealthier & Healthier

by Andi Dwyer, Director of Health Promotion  A few weeks ago at the American Society of Clinical Oncology meeting, prevention was a hot topic! The news of prevention and exploring opportunities for early detection was extremely interesting. Before the next ASCO meeting, I have high hopes that we all can identify ways to bring early detection and…  Read More

Fight Colorectal Cancer Releases “Guide in the Fight” Resource Book for Stage III & Stage IV Colorectal Cancer Patients

FOR IMMEDIATE RELEASE ALEXANDRIA, Va., June 17, 2014 – Today Fight Colorectal Cancer released its new patient education resource, Your Guide in the Fight. Your Guide in the Fight answers common questions and provides practical tips for those fighting stage III and stage IV colorectal cancer (advanced stage disease.) The resource walks patients through a cancer…  Read More

First-Line Treatment Approved for Stage IV Colorectal Cancer

There is new first-line treatment (standard of care to start treatment) giving as many as 60% of the stage IV colorectal cancer patients more options for treatment. Previously, most stage IV patients undergoing chemotherapy would be recommended to go on FOLFOX and bevacizumab (Avastin). Patients would receive this first set of drugs (called first-line) and if…  Read More